Protonix Average Price Increases By 8% As Wyeth Cuts Medicaid Contracts
This article was originally published in The Pink Sheet Daily
Executive Summary
Focus on key managed care accounts and elimination of some state contracts has resulted in an 8% weighted average price increase compared to first quarter 2004. Protonix shows 10% total prescription growth, but posts flat sales due to 9% inventory workdown.